TOKYO -- Japan has requested Swiss pharmaceutical group Roche and other companies to increase production of antigen test kits that can simultaneously determine infection with COVID-19 and seasonal influenza.
In response to the request, companies are taking measures to make 35-40 million doses available this winter, according to a government official, when simultaneous outbreak of COVID and flu are expected.
re.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
